Virtonomy.io
Data driven clinical trials on virtual patients
Virtonomy is shortening time-to-market of medical products by conducting data driven studies on virtual patients. Our solution is based on an ever-expanding database to reflect anatomical variability, demographic diversity and pathological conditions.
The development costs of medical devices are rising along with time-to-market. Digital solutions are the only way to face these challenges.
Reduce risks, time and cost
by performing data-driven device development & virtual clinical trials using statistical analysis, simulations & optimization
Master new regulatory & ethical demands
by performing data-driven device development & virtual clinical trials using statistical analysis, simulations & optimization
Safe animal & clinical trials
by accessing Digital Twins based on clinical data of thousands of humans and animals
Use virtual patients as digital evidence
Regulatory viewpoint / FDA’s Perspective
FDA has identified an important role for modeling and simulation in its strategic priorities.
Useful links:
“FDA’s Office of Science and Engineering Laboratories (OSEL) has committed significant resources for transforming computational modeling from a valuable scientific tool to a valuable regulatory tool because of its potential for significant cost-savings in evaluating medical devices, simulating performance under scenarios that may not be possible with human use or that could more effectively be evaluated with simulation.”
v-Patients
Our end-to-end digital twin solution
The virtual trial platform supports the full product life-cycle of medical device development.
Virtual Patients
Digital twins to better understand your target anatomy.
Statistical Analysis
Population based engineering to treat the maximum number of patients.
Simulation
Simulate human and animal variability.
Regulatory Reporting
Three-dimensional visualization for marketing, education and training.
Understanding patient anatomies and optimizing anatomical fit directly impacts the fate of development projects. Virtonomy’s combined expertise in specific pathologies, device/patient interactions and state of the art therapy options is tremendously valuable for anyone looking to create or optimize cardiovascular technologies.
Dr. Maximilian Kütting, Director R&D
How can you shorten your time-to market?
Talk to our experts to find out how you can utilize digital twins for your specific medical device.
Supported by
